Drug profile · INN
vinorelbine tartrate
VINORELBINE TARTRATE
vinorelbine tartrate (VINORELBINE TARTRATE) is a tubulin inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — vinorelbine tartrate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 3
- Data quality
- 0.89
Quick answer
vinorelbine tartrate (VINORELBINE TARTRATE) is a tubulin inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Tubulin inhibitor
Primary target: Tubulin
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is vinorelbine tartrate?
vinorelbine tartrate (VINORELBINE TARTRATE) is a tubulin inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for vinorelbine tartrate?
VINORELBINE TARTRATE is a marketed brand name for vinorelbine tartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vinorelbine tartrate?
vinorelbine tartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.